SFJ Pharma, Pfizer collaborate for dacomitinib trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012
Singapore: SFJ Pharmaceuticals, primarily focused on funding and executing phase III studies of drugs, has entered into ...Read more
BMS stops Hepatitis C inhibitor development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Aug, 2012
Singapore: Bristol-Myers Squibb has discontinued the development of BMS-986094 (formerly known as INX-189), a nucleotide...Read more
FDA approves Bayer thromboembolic BP drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2013
Singapore: Bayer HealthCare has recieved US FDA approval for Adempas (riociguat) tablets for the treatment of adults wit...Read more
FDA red signal for Genzyme, Bayer multiple sclerosis drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 03 Sep, 2012
Singapore: Genzyme, a Sanofi company, received a Refuse to File letter from the US FDA in response to the supplemental B...Read more
NIH funds $45 mn Alzheimer's drug development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Sep, 2013
Singapore: The National Institutes of Health (NIH) is funding $45 million for research aimed at preventing Alzheimer's ...Read more
Singapore firm to launch next-gen cancer study device
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 May, 2014
Singapore: Singapore's emerging company Clearbridge BioMedics plans to launch its ClearCell FX System at American Societ...Read more
CSL files biologics license plea with FDA
Drug Discovery | Regulatory | By BioSpectrum Bureau | 3 Comment | 30 May, 2012
Singapore: The US Food and Drug Administration (FDA) has accepted Australia-based CSL Behring's biologics license applic...Read more
Japanese biomedical firm sets up lab in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2013
Singapore: Japan-based biopharmaceutical firm, Kyowa Hakko Kirin (KHK) has setup Singapore Translational Research Labora...Read more
AB Sciex launches data analysis software
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Aug, 2013
Singapore: AB Sciex, a global leader in analytical technologies, has launched MasterView Software, a new software applic...Read more
LCT conducts first implant of regenerative therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013
Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment fo...Read more
GSK melanoma phase III misses co-primary endpoint
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2013
Singapore: GlaxoSmithKline's (GSK) Dermai study, a phase III, randomized, blinded, placebo-controlled Mage-A3 cancer imm...Read more
Bayer cancer drug Stivarga gets Singapore nod
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2013
Singapore: The Health Sciences Authority (HSA) of Singapore has approved Bayer' Stivarga, the first oral targeted therap...Read more
Eye diseases cost upto $27bn to Europe
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2013
Singapore: European Forum Against Blindness (EFAB) has revealed the results of a six-country study which analyzed the ec...Read more
Gilead hepatitis drug to axe treatment time by half
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 09 Apr, 2013
Singapore: Gilead Sciences has submitted a New Drug Application (NDA) to the US FDA for approval of sofosbuvir, a once-d...Read more
Gilead leukemia study gets complete response
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2013
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...Read more
Advinus collaborates with P2D Bioscience for ADHD
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2012
Bangalore: Advinus Therapeutics, a Bangalore-based drug discovery and development company, and P2D Bioscience, a CNS-foc...Read more
All you need to know about Glivec
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 01 Apr, 2013
What is Glivec?Glivec or imatinib mesylate is the first of a class of drugs that specifically inhibits a target enzyme, ...Read more
Cytomegalovirus treatments to improve
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generall...Read more